You are currently viewing a new version of our website. To view the old version click .
Journal: VaccinesVolume: 14Number: 3
Article: Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18–49 Years of Age Enrolled at Center for Indigenous Health Sites
  • Authors:
  • Laura L. Hammitt1,*,
  • Ulrike K. Buchwald2 and
  • Jennifer McCauley2
  • et al.
Link: https://www.mdpi.com/2076-393X/14/1/3

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.